State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report.

J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52). doi: 10.1093/jncimonographs/lgx003. Xi D1, Bao T1, Chen Q1, Chen S1, Cheng YC1, Cullen J1, Frank DA1, Friedberg JW1, Kronish I1, Lee JE1, Levine M1, Li P1, Li S1, Lu W1, Mao JJ1, O'Keefe S1, Rubinstein L1, Shah MA1, Standish L1, Paller CJ1, Chu E1. Author information 1 Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; Memorial Sloan Kettering Cancer Center, New York, NY; University of Kansas, Lawrence, KS; University of Florida, Gainsville, FL; Yale University, New Haven, CT; University of Iowa, Iowa City, IA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; University of Rochester Medical Center, Rochester, NY; Columbia University Medical Center, New York, NY; The University of Texas MD Anderson Cancer Center, Houston, TX; Peking University Cancer Hospital, Beijing, China; University of Pittsburgh, Pittsburgh, PA; Weill Cornell Medicine at Cornell University, New York, NY; Bastyr University, Kenmore, WA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; Tsinghua University, Beijing, China. Abstract In May 2016, the Office of Cancer Complementary and Alternative Medicine, Division of Cancer Diagnosis and Treatment, of the National Cancer Institute convened a special workshop focused on the State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research. The current state of the science, gaps, and future opportunities were reviewed and discussed by a distinguished panel of experts in this field of research, and the highlights of this meeting are reported herein. PMID: 29140484 DOI: 10.1093/jncimonographs/lgx003